thalidomide has been researched along with Choroid Diseases in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Choroid Diseases: Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient had a recurrence of the choroidal neovascular membrane eight months after the start of thalidomide therapy." | 1.29 | Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide. ( Gorin, MB; Ip, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokouchi, H | 1 |
| Oshitari, T | 1 |
| Baba, T | 1 |
| Yamamoto, S | 1 |
| Ip, M | 1 |
| Gorin, MB | 1 |
2 other studies available for thalidomide and Choroid Diseases
| Article | Year |
|---|---|
Thalidomide reduces choroidal thickness and optic disc edema in a patient with POEMS syndrome.
Topics: Angiogenesis Inhibitors; Choroid Diseases; Female; Humans; Middle Aged; Papilledema; POEMS Syndrome; | 2015 |
Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide.
Topics: Adult; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Fundus Oculi; Humans; Immunosuppr | 1996 |